文献速递免疫规划传染病防控与疫情报告

牛疱疹病毒5型重组糖蛋白D疫苗在牛体内的免疫应答

Immune responses in bovines to recombinant glycoprotein D of bovine herpesvirus type 5 as vaccine antigen.
PubMed 文献 · Vaccine · 2018-10-28

本研究将72头小母牛随机分6组,比较含重组BoHV-5 gD(rgD5)疫苗与商品苗及对照的免疫效果。含灭活BoHV-5加rgD5的疫苗组总IgG较商品苗和对照组显著升高5倍(p<0.01),中和抗体滴度高4倍(p<0.01),提示rgD5是BoHV-1/5流行区有前景的疫苗抗原。

要点

  • 含iBoHV-5+rgD5疫苗组总IgG较商品苗和对照组显著升高5倍(p<0.01)。
  • 该组BoHV-1和BoHV-5中和抗体滴度显著高4倍(p<0.01)。
  • rgD5保留重要表位,可刺激牛体液免疫并中和BoHV-1和BoHV-5。

核心结论

  • rgD5保留重要表位,能刺激牛体液免疫应答并中和BoHV-1和BoHV-5,有望作为BoHV-1/5流行区疫苗抗原。

研究设计与样本

  • 72头小母牛随机分6组,每组12头,分别接种不同配方疫苗或对照,26天间隔两剂,首免后357天第三剂。

主要发现

  • 含iBoHV-5+rgD5疫苗组总IgG较商品苗和对照组显著升高5倍(p<0.01)。
  • 该组血清rgD5特异性IgG1和IgG2a水平显著升高(p<0.05)。
  • 该组BoHV-1和BoHV-5中和抗体滴度显著高4倍(p<0.01)。

关键数值与推荐

  • Group 2为iBoHV-5联合100 µg rgD5(ISA50V2佐剂),Group 3为100 µg rgD5(ISA50V2佐剂),Group 4为100 µg rgD5(Al(OH)3佐剂)。

临床怎么用

  • 提示rgD5可作为BoHV-1和BoHV-5流行区疫苗候选抗原,但需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bovine herpesvirus 5 (BoHV-5) is responsible for outbreaks of meningoencephalitis that cause important economic losses in young cattle. BoHV-5 glycoprotein D (gD5) is essential for attachment and penetration into permissive cells and targeting of host immune systems, inducing strong humoral and cellular immune responses. The aim of this study was to evaluate the vaccinal immune response of vaccines formulated with the recombinant BoHV-5 gD (rgD5) in bovines. For the experiment, 72 heifers were randomly allotted into 6 different groups with 12 animals each. Group 1: vaccine formulated using inactivated BoHV-5 (iBoHV-5) adjuvanted with ISA50V2; Group 2: iBoHV-5 associated with 100 µg of rgD5 adjuvanted with ISA50V2; Group 3: 100 µg of rgD5 adjuvanted with ISA50V2; Group 4: 100 µg of rgD5 adjuvanted with Al(OH)3; Group 5: commercial vaccine; and Group 6: control group. Two doses were administered in a 26-day interval and the third after 357 days from primo vaccination. Cattle vaccinated with the vaccines formulated with iBoHV-5 plus rgD5 showed a significant (p < 0.01) five-fold increase in total immunoglobulin G (IgG) for BoHV-5, BoHV-1, and rgD5 as compared with the commercial and control groups. Also, a significant (p < 0.05) increase in IgG1 and IgG2a levels was induced in serum for rgD5. In addition, these same vaccines showed significant (p < 0.01) four-fold higher titers of BoHV-1 and -5 neutralizing antibodies. The results demonstrated that the rgD5 conserved important epitopes that were able to stimulate bovine humoral immunity response capable of viral neutralization of BoHV-1 and -5, suggesting it as a promising vaccine antigen to be used in vaccine for BoHV-1 and -5 endemic areas.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Araujo IL, Dummer LA, Rodrigues PRC, et al. Immune responses in bovines to recombinant glycoprotein D of bovine herpesvirus type 5 as vaccine antigen. Vaccine. 2018. PMID: 30381153. doi:10.1016/j.vaccine.2018.10.080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。